Zhejiang NHU company profile
Company profile
Zhejiang NHU has 11,508 employees and is headquartered in Xinchang, China.
Sales reach customers across China and in export markets abroad. The group operates through pharmaceutical and chemical segments, and its products include nutrition products, flavors and fragrances, high-performance polymers, and active pharmaceutical ingredients. Animal feed producers buy vitamins, amino acids and carotenoids for poultry, pigs, ruminants and farmed fish, while supplement and personal care makers use vitamins, coenzyme Q10 and taurine. Fragrance houses draw on fruity, floral and herbal compounds, and industrial buyers take chemical intermediates for construction chemicals, crop protection and fertilizers.
In the fiscal year ended December 2025, revenue rose 3.0% to 22.3 billion yuan and net profit reached 6.8 billion yuan. The company has 11,508 employees and is headquartered in Xinchang, China. Founded in 1999, it operates as a subsidiary of NHU Holding Group Co., Ltd.
Company facts
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- China
- Headquarters
- No.418 Xinchang Dadao West Road, 312500, Xinchang
- Employees
- 11,508
- Chief executive
- Bai Shan Hu
- Founded
- 1999
- Fiscal year
- January - December
- Listing
- 002001 · SZSE
- Currency
- CNY
- ISIN
- CNE000001J84
- Website
- cnhu.com
Zhejiang NHU and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| Zhejiang NHU002001 | China | $12.31B | 11,508 | 33.8% | 10.9 |
| CiplaCIPLA | India | $12.03B | 31,369 | 13.0% | 38.8 |
| Zydus LifesciencesZYDUSLIFE | India | $12.85B | 29,980 | 17.2% | 28.8 |
| Laurus LabsLAURUSLABS | India | $14.01B | 7,059 | 24.1% | 97.8 |
| Yunnan Baiyao Group000538 | China | $15.07B | 9,286 | 11.2% | 19.3 |
| Eisai4523 | Japan | $9.34B | 10,543 | 5.7% | 33.9 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
